Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patients. 1987

E R Korpi, and J E Kleinman, and S I Goodman, and R J Wyatt
Neuropsychiatry Branch, National Institute of Mental Health, Saint Elizabeths Hospital, Washington, DC 20032.

Neurotransmitter amino acids were measured in post-mortem caudate nucleus, nucleus accumbens, frontal cortex, amygdala, and hypothalamus of chronic schizophrenic and normal control subjects. The concentrations of upsilon-aminobutyric acid (GABA), taurine, glycine-threonine, glutamate, aspartate, glutamine, tryptophan, and alanine were similar in both groups, with the exception of decreased GABA and tryptophan in the amygdala of the schizophrenic group. Strong positive correlations were obtained between the concentration of tryptophan, a putative agonal status marker of post-mortem brain tissue, and the concentration of GABA in all brain areas. When the GABA concentrations were adjusted for tryptophan concentrations in amygdala, the difference between the schizophrenic and control samples was no longer significant, suggesting that the original difference may have been due to different agonal or post-mortem changes in the tissues. There were, however, no significant correlations between GABA and post-mortem interval. The present results do not support the aminoacidergic hypotheses of chronic schizophrenia, although a GABA deficiency cannot be entirely excluded.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011180 Postmortem Changes Physiological changes that occur in bodies after death. Adipocere,Algor Mortis,Cruor,Livor Mortis,Change, Postmortem,Changes, Postmortem,Postmortem Change
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D005680 gamma-Aminobutyric Acid The most common inhibitory neurotransmitter in the central nervous system. 4-Aminobutyric Acid,GABA,4-Aminobutanoic Acid,Aminalon,Aminalone,Gammalon,Lithium GABA,gamma-Aminobutyric Acid, Calcium Salt (2:1),gamma-Aminobutyric Acid, Hydrochloride,gamma-Aminobutyric Acid, Monolithium Salt,gamma-Aminobutyric Acid, Monosodium Salt,gamma-Aminobutyric Acid, Zinc Salt (2:1),4 Aminobutanoic Acid,4 Aminobutyric Acid,Acid, Hydrochloride gamma-Aminobutyric,GABA, Lithium,Hydrochloride gamma-Aminobutyric Acid,gamma Aminobutyric Acid,gamma Aminobutyric Acid, Hydrochloride,gamma Aminobutyric Acid, Monolithium Salt,gamma Aminobutyric Acid, Monosodium Salt
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

E R Korpi, and J E Kleinman, and S I Goodman, and R J Wyatt
December 1987, The British journal of psychiatry : the journal of mental science,
E R Korpi, and J E Kleinman, and S I Goodman, and R J Wyatt
August 1988, Acta psychiatrica Scandinavica,
E R Korpi, and J E Kleinman, and S I Goodman, and R J Wyatt
June 1981, Lancet (London, England),
E R Korpi, and J E Kleinman, and S I Goodman, and R J Wyatt
May 1981, Lancet (London, England),
E R Korpi, and J E Kleinman, and S I Goodman, and R J Wyatt
February 1999, Neuropathology and applied neurobiology,
E R Korpi, and J E Kleinman, and S I Goodman, and R J Wyatt
June 1997, Biochemistry and molecular biology international,
E R Korpi, and J E Kleinman, and S I Goodman, and R J Wyatt
January 1987, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica,
E R Korpi, and J E Kleinman, and S I Goodman, and R J Wyatt
October 1995, Archives of general psychiatry,
E R Korpi, and J E Kleinman, and S I Goodman, and R J Wyatt
January 1982, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica,
E R Korpi, and J E Kleinman, and S I Goodman, and R J Wyatt
November 2007, Schizophrenia research,
Copied contents to your clipboard!